Open Access

Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

  • Yasin Şenbabaoğlu1, 15Email author,
  • Ron S. Gejman2, 14,
  • Andrew G. Winer3,
  • Ming Liu4,
  • Eliezer M. Van Allen5,
  • Guillermo de Velasco5,
  • Diana Miao5,
  • Irina Ostrovnaya6,
  • Esther Drill6,
  • Augustin Luna1,
  • Nils Weinhold1,
  • William Lee1, 7,
  • Brandon J. Manley3,
  • Danny N. Khalil13,
  • Samuel D. Kaffenberger3,
  • Yingbei Chen8,
  • Ludmila Danilova9, 10,
  • Martin H. Voss11,
  • Jonathan A. Coleman3,
  • Paul Russo3,
  • Victor E. Reuter8,
  • Timothy A. Chan7, 12, 14,
  • Emily H. Cheng8, 12,
  • David A. Scheinberg2, 13, 14,
  • Ming O. Li4,
  • Toni K. Choueiri5,
  • James J. Hsieh11, 12,
  • Chris Sander1 and
  • A. Ari Hakimi1, 3Email author
Contributed equally
Genome Biology201718:46

DOI: 10.1186/s13059-017-1180-8

Received: 23 February 2017

Accepted: 23 February 2017

Published: 1 March 2017

The original article was published in Genome Biology 2016 17:231

Erratum

After publication of this article [1] we noticed that authors Yasin Şenbabaoğlu and Ron S. Gejman were omitted as equal contributors. This has now been corrected in the author list.

The publisher apologises for these errors.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Computational Biology Center, Memorial Sloan Kettering Cancer Center
(2)
Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center
(3)
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
(4)
Immunology Program, Memorial Sloan Kettering Cancer Center
(5)
Department of Medical Oncology, Dana-Farber Cancer Institute
(6)
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center
(7)
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center
(8)
Department of Pathology, Memorial Sloan Kettering Cancer Center
(9)
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
(10)
Vavilov Institute of General Genetics, Russian Academy of Sciences
(11)
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
(12)
Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center
(13)
Department of Medicine, Memorial Sloan Kettering Cancer Center
(14)
Weill Cornell Medical College
(15)
Present address: Swim Across America/Ludwig Collaborative Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center

Reference

  1. Şenbabaoğlu Y, Gejman RS, Winer AG, Liu M, Van Allen EM, de Velasco G, et al. Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures. Genome Biology. 2016;17:231.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement